期刊文献+

高脂血症导致慢性肾脏病机制的研究进展 被引量:4

Advances in research on the mechanism of chronic kidney disease caused by hyperlipidemia
下载PDF
导出
摘要 慢性肾脏病(chronic kidney diseases,CKD)患者常伴发脂代谢异常,同时多种与脂代谢异常有关的疾病如糖尿病、高血压亦常合并CKD。尽管人们认为血脂异常可能是由肾脏疾病引发的,但大量的临床和实验研究支持脂代谢紊乱会导致肾脏疾病的发生并加速其恶化。高脂血症在诱导肾损害中起着重要作用并且是CKD进展的独立危险因素。虽然脂质诱导肾损害的潜在病理生理机制尚未被阐明,但一些研究提示了脂蛋白、甘油三脂、胆固醇和游离脂肪酸影响肾小球和肾小管功能的新机制。作者将重点介绍高脂血症在CKD中致病机制的研究进展。 Chronic kidney diseases(CKD)patients have abnormal lipid metabolism,and a variety of diseases associated with abnormal lipid metabolism such as diabetes and hypertension are combined with CKD.Although dyslipidemia may be thought to be caused by kidney disease,a large number of clinical and experimental studies support the disorder of lipid metabolism leading to kidney disease and accelerating its progression.Hyperlipidemia plays an important role in the induction of renal damage and is an independent risk factor for the progression of CKD.Although the underlying pathophysiological mechanisms of lipid-induced renal damage have not been elucidated,some studies suggest that lipoproteins,triglyceride,cholesterol,and free fatty acid affect kidneys through new mechanism of glomerular and tubular function.This review will focus on the research progress of the pathogenesis of hyperlipidemia in CKD.
作者 张敏 高霞 ZHANG Min;GAO Xia(Ningxia Medical University,Yinchuan Ningxia 750004,China;Department of Pediatrics,Gansu Provincial People’s Hospital,Lanzhou Gansu 730000,China)
出处 《转化医学杂志》 2020年第1期61-64,F0003,共5页 Translational Medicine Journal
基金 国家自然科学基金(81360114,81660130) 甘肃省卫计委行业项目(GSWSKY-2015-12)
关键词 高脂血症 慢性肾脏病 发病机制 研究进展 Hyperlipidemia Chronic kidney disease(CKD) Pathogenesis Research progress
  • 相关文献

参考文献2

二级参考文献23

  • 1林善锬.肾素-血管紧张素系统认识的演变及其临床意义[J].中华高血压杂志,2007,15(z1):3-5. 被引量:5
  • 2Moorhead JF, Chan MK, EI-Nahas M, et al. I.ipid nephrotoxici- ty in chronic progressive glomerular and tubulo-inlerstitial disease [J]. Lancet, 1982,2(8311) : 1309-1311.
  • 3Singh BM, Mehta JL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease[J]. Arch Intern Med,2003,163( 11 ) : 1296-1304.
  • 4Zhang Y, Naggar JC, Welzig CM, el al. Simvastatin inhibits an- giotensin Ⅱ-induced abdominal aortic aneurysm formation in apo- lipoprotein E-knockout mice: possible role of ERK[J]. Arterio- seler Thromb Vasc Biol,2009,29(11) :1764-1771.
  • 5Kantorowicz L, Valego NK, Tang L, et al. Plasma and renal re- nin concentrations in adult sheep after prenatal betamethasone ex- posure[J]. Reprod Sci,2008,15(8) :831-838.
  • 6Trevisan R, Dodesini AR, Lepore G. I.ipids and renal disease [J]. J Am Soc Nephrol,2006,17(4 Suppl 2) :S145-147.
  • 7Liu Y. New insights into epithelial-mesenchymal transition in kid- ney fibrosis[J]. J Am Soc Nephrol,2010,21(2) :212-222.
  • 8Kalluri R, Neilson EG. Epithelial-mesenchymal transition and tts implications for fibrosis [J]. J Clin Invest, 2003, 112 (12): 1776- 1784.
  • 9Hollenberg NK, Price DA, Fisher ND, et al. Glomerular hemo- dynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus[J]. Kidney Int, 2003,63 ( 1 ) : 172-178.
  • 10Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for lhe kidney and systemic tissues in blood pressure regulation by the re- nin-angiotensin system [J]. J Clin Invest, 2005, 115 ( 4 ) : 1092- 1099.

共引文献9

同被引文献53

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部